ArticleBMC cardiovascular disorders2026
Prognostic value of left atrioventricular coupling index in non-ischemic dilated cardiomyopathy: a cardiovascular magnetic resonance study.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundLeft atrioventricular coupling index (LACI) has been recognized for its prognostic significance across various cardiovascular diseases; however, its role in non-ischemic dilated cardiomyopathy (NIDCM) remains largely unexplored. This study aimed to evaluate the prognostic value of cardiovascular magnetic resonance (CMR)-derived LACI in patients with NIDCM and its ability to improve risk stratification.
methodsThis prospective, single-center cohort study enrolled 612 patients with NIDCM and 100 age- and sex-matched healthy volunteers who underwent CMR imaging between June 2012 and July 2019. LACI was defined as the ratio of left atrial end-diastolic volume (LAVmin) to left ventricular end-diastolic volume (LVEDV) assessed by CMR. The primary endpoint was a composite of all-cause mortality and heart transplantation. Cox proportional hazards models, Kaplan-Meier survival analysis, and model discrimination assessed by C-index were used to evaluate the prognostic value of LACI.
resultsDuring a median follow-up of 63 months, 183 patients reached the primary endpoint. Patients with NIDCM had significantly higher LACI values than healthy volunteers (30 ± 16% vs. 19 ± 6%, P < 0.001). In multivariable Cox regression analysis, LACI was independently associated with the primary endpoint (hazard ratio per 5% increase, 1.05; P = 0.001). A LACI threshold > 30% was associated with an increased risk of the primary endpoint (P < 0.001). Incorporation of LACI into clinical and conventional CMR models (age, sex, systolic blood pressure, New York Heart Association class, left ventricular ejection fraction, left ventricular mass index, and late gadolinium enhancement presence) improved model discrimination (C-index 0.757 vs. 0.738, p < 0.001). The discriminative performance of the LACI-based model was comparable to that of a component-based model including LVEDVi and LAVimin (C-index 0.757 vs. 0.755), further supporting its prognostic utility.
conclusionsIn patients with NIDCM, higher LACI is independently associated with adverse clinical outcomes and provides modest incremental prognostic information beyond established clinical and CMR parameters. LACI represents a simple and reproducible CMR-derived marker with potential value for risk stratification in NIDCM.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.